Chemclin Diagnostics Co., Ltd. Stock
Equities
688468
CNE100005311
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.43 CNY | +1.64% | +13.61% | -31.14% |
Sales 2022 | 465M 64.26M | Sales 2023 | 445M 61.51M | Capitalization | 4.33B 598M |
---|---|---|---|---|---|
Net income 2022 | 153M 21.13M | Net income 2023 | 147M 20.3M | EV / Sales 2022 | 6.07 x |
Net cash position 2022 | 973M 134M | Net cash position 2023 | 684M 94.47M | EV / Sales 2023 | 8.18 x |
P/E ratio 2022 |
24.9
x | P/E ratio 2023 |
29.2
x | Employees | 690 |
Yield 2022 |
3.66% | Yield 2023 |
-
| Free-Float | 35.88% |
1 day | +1.64% | ||
1 week | +13.61% | ||
Current month | +1.78% | ||
1 month | +1.78% | ||
3 months | -12.69% | ||
6 months | -28.07% | ||
Current year | -31.14% |
Managers | Title | Age | Since |
---|---|---|---|
Lin Li
CEO | Chief Executive Officer | 62 | 07-12-31 |
Yan Ling Huang
DFI | Director of Finance/CFO | 49 | 07-12-31 |
Hong Yan Fu
BRD | Director/Board Member | 50 | 06-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jun Jie Zhang
BRD | Director/Board Member | 47 | 19-09-10 |
Jie Zhang
BRD | Director/Board Member | 71 | 19-10-23 |
Lin Li
CEO | Chief Executive Officer | 62 | 07-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 7.43 | +1.64% | 6,089,005 |
24-04-29 | 7.31 | +4.88% | 6,699,887 |
24-04-26 | 6.97 | +2.20% | 3,002,319 |
24-04-25 | 6.82 | +1.04% | 3,363,896 |
24-04-24 | 6.75 | +0.75% | 3,506,623 |
End-of-day quote Shanghai S.E., April 29, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-31.14% | 412M | |
-0.60% | 12.62B | |
-9.59% | 7.67B | |
+1.82% | 5.41B | |
+0.02% | 4.57B | |
-51.89% | 3.22B | |
+6.42% | 2.59B | |
-14.59% | 2.05B | |
-8.29% | 1.79B | |
+1.67% | 1.76B |
- Stock Market
- Equities
- 688468 Stock